Cargando…
Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer’s Disease
Recently, imaging biomarkers have gained importance for the characterization of patients with Alzheimer’s disease; however, the relationship between regional biomarker expression and cognitive function remains unclear. In our study, we investigated associations between scores on CERAD neuropsycholog...
Autores principales: | Hedderich, Dennis M., Drost, René, Goldhardt, Oliver, Ortner, Marion, Müller-Sarnowski, Felix, Diehl-Schmid, Janine, Zimmer, Claus, Förstl, Hans, Yakushev, Igor, Jahn, Thomas, Grimmer, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438836/ https://www.ncbi.nlm.nih.gov/pubmed/32903760 http://dx.doi.org/10.3389/fpsyt.2020.00793 |
Ejemplares similares
-
Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020) -
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2019) -
Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer’s Disease Regardless of Concomitant Small Vessel Disease
por: Ortner, Marion, et al.
Publicado: (2023) -
The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
por: Amft, Michaela, et al.
Publicado: (2022) -
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels
por: Ortner, Marion, et al.
Publicado: (2020)